GxPinnacle Logo
Skip to content

What Do Inspectors Check for Local PV and Affiliate Responsibilities?

Pharmacovigilance systems must define clear local and affiliate responsibilities within the global PV framework. Regulators expect explicit ownership of local reporting, escalation, implementation, and coordination with global pharmacovigilance oversight.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Inspectors assess whether local affiliates and country-level pharmacovigilance roles are clearly defined within the global PV system. They review how responsibilities for local reporting, escalation, and authority interaction are allocated and controlled. They also assess whether affiliate roles operate consistently within the global pharmacovigilance framework.
  • Local roles must support implementation of global PV procedures while meeting local regulatory obligations.
  • Responsibilities for local case intake, health authority interactions, literature surveillance, and escalation must be documented.
  • Affiliate roles must align with the global PV framework and reporting lines to central oversight.
  • Local responsibilities must be clearly coordinated with QPPV oversight and global governance structures.
  • Inspection-ready evidence must demonstrate that local and affiliate responsibilities are defined, implemented, and integrated into the wider PV system.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Local and affiliate pharmacovigilance responsibilities must be clearly defined.
  • Local roles must align with the global PV system and governance structure.
  • Country-specific obligations must be allocated and documented.
  • Affiliate roles must support timely escalation and compliant reporting.
  • Global oversight must maintain visibility and control of local PV execution.

Summary

Inspectors assess whether local affiliates and country-level pharmacovigilance roles are clearly defined within the global PV system. They typically review local reporting obligations, escalation pathways, affiliate role descriptions, and evidence that local responsibilities align with global pharmacovigilance oversight and procedures.

Common questions

These are the questions this page is designed to answer directly.

  • What are local pharmacovigilance responsibilities?
  • What do inspectors check for affiliate PV responsibilities?
  • How are local PV roles managed in a global pharmacovigilance system?
  • What are affiliate responsibilities in pharmacovigilance?
  • How do local PV teams support the global PV system?
  • What local safety responsibilities must be defined?
  • How do regulators assess local PV accountability?
  • What is the role of affiliates in pharmacovigilance?
  • How are local reporting obligations managed in PV?
  • How do global and local PV roles interact?

Evidence objects inspectors expect

Local PV Role Descriptions

  • Defined responsibilities for local safety officers or affiliate PV leads
  • Local obligations for case receipt, forwarding, and escalation
  • Responsibilities for local health authority communication
  • Defined interaction with global PV functions

Global-to-Local Role Matrix

  • Allocation of responsibilities between central PV and affiliates
  • Clear ownership of local versus global activities
  • Defined handoff points between affiliate and central teams
  • Mapping of local reporting and implementation responsibilities

Local Reporting and Escalation Procedures

  • Local timelines for forwarding safety information
  • Escalation of urgent safety issues to global PV
  • Defined handling of local authority requests or inspections
  • Country-specific obligations captured within the PV system

Affiliate Oversight and Governance Evidence

  • Governance meetings involving affiliate PV representatives
  • Evidence of communication between global and local PV roles
  • Review of affiliate compliance with PV obligations
  • Documentation of oversight by QPPV or central PV leadership

Backup and Coverage Arrangements

  • Defined deputy or alternate coverage for local PV roles
  • Continuity arrangements during absence or role changes
  • Delegation records for temporary local responsibility transfer
  • Evidence of uninterrupted local PV coverage

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for a clearly defined pharmacovigilance system with structured responsibilities across all levels
  • GVP Module VI – local handling and reporting responsibilities must support compliant ICSR management
  • ICH E2D – post-approval safety data management requires clear operational responsibilities across reporting entities
  • MHRA GPvP guidance – local and affiliate roles must support compliant pharmacovigilance execution
  • FDA pharmacovigilance guidance – responsibilities must be defined where local or regional activities support safety reporting

Typical Inspection Questions (What Inspectors Ask)

  • What are the responsibilities of your local affiliate PV role?
  • How do local teams interact with central pharmacovigilance?
  • Who is responsible for local case forwarding and escalation?
  • How are local authority queries handled?
  • How do you ensure affiliates follow the global PV system?

Failure patterns

Local or affiliate responsibilities are unclear or not documented.

Affiliates perform PV activities without alignment to global procedures.

Local reporting or escalation obligations are missed or delayed.

Global leadership lacks visibility of affiliate execution.

Backup and coverage arrangements for local PV roles are missing or ineffective.

What good looks like

  • A clearly documented local and affiliate PV responsibility model.
  • Defined coordination between global and local PV functions.
  • Clear ownership of local regulatory, reporting, and escalation tasks.
  • Ongoing oversight of affiliate execution by central PV leadership.
  • Continuous local coverage with documented backup arrangements.

Operationalisation

  • Define local and affiliate PV roles within the broader PV organisational framework.
  • Map local responsibilities against global ownership and governance.
  • Document country-specific obligations for reporting, escalation, and authority communication.
  • Ensure local teams are trained on global PV procedures and local requirements.
  • Implement oversight and communication routines between central and affiliate roles.
  • Maintain backup and delegation arrangements for local PV continuity.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

What are local pharmacovigilance responsibilities?

Local pharmacovigilance responsibilities typically include case receipt and forwarding, local health authority interactions, implementation of global PV procedures, escalation of safety issues, and support for local compliance obligations.

Who is responsible for pharmacovigilance at the local affiliate level?

Local pharmacovigilance responsibility typically sits with affiliate or local safety roles, who are responsible for case intake, local reporting obligations, and escalation, operating under the oversight of the global pharmacovigilance system and QPPV.

What is the role of affiliates in pharmacovigilance?

Affiliates support the global PV system by carrying out country-specific activities such as local case handling, regulatory communication, literature monitoring where required, and escalation of safety information to central teams.

How do local and global PV roles interact?

Local and global PV roles interact through defined reporting lines, handoff points, governance meetings, escalation processes, and shared procedures that ensure consistent execution of pharmacovigilance obligations.

Do inspectors review affiliate pharmacovigilance responsibilities?

Yes. Inspectors review whether affiliate roles are defined clearly, aligned to the global PV system, and capable of meeting local regulatory obligations.

Who is responsible for local reporting obligations in pharmacovigilance?

Local reporting responsibilities should be explicitly allocated within the PV system, but they typically sit with affiliate or local PV roles operating under the oversight of central pharmacovigilance leadership.

How do companies ensure continuous local PV coverage?

Companies ensure continuous local PV coverage through backup roles, delegation procedures, documented handovers, and governance arrangements that maintain uninterrupted responsibility.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source

FDA

ICH

MHRA